Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's sumatriptan
succinate 100 mg tablets to GSK's Imitrex® 100 mg tablets following a single, oral 100 mg (1
x 100 mg) dose administration under fasting conditions.